[1]
“LOW-DOSE VERSUS STANDARD-DOSE RITUXIMAB IN VESICULOBULLOUS DISORDERS: A COMPARATIVE EFFECTIVENESS STUDY”, A-JMRHS, vol. 4, no. 2, pp. 1638–1642, Jul. 2026, doi: 10.65605/a-jmrhs.2026.v04.i02.pp1638-1642.